HeartLung.AI will be the only company at ESC Congress 2026 presenting this high number of accepted scientific studies. The achievement reflects the strength of the company’s research program and the ...

Sophia Antipolis, 4 September 2024: Some 32,000 health professionals from 171 countries attended the event in London, which covered all the fields of cardiovascular medicine. The spotlight of this ...

The European Society of Cardiology (ESC) Congress 2024 will take place in London, England, August 30 to September 2. In rooms named to mirror the international contingent that will be attending the ...

WAYNE, PA.--(BUSINESS WIRE)--XyloCor Therapeutics, Inc., a clinical‑stage biopharmaceutical company developing novel gene therapies for cardiovascular disease, today presented results from the Phase 2 ...

Cytokinetics Incorporated (NASDAQ:CYTK) is one of the biotech stocks to buy according to Wall Street analysts. On July 10, Cytokinetics announced that five presentations related to their ...